The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation
Open accessAbstract
AIM: Different strains of bifidobacteria were analysed for their effects on HT-29 intestinal epithelial cells (IECs) in in vitro models both of the non-inflamed and inflamed intestinal epithelium. METHODS: A reporter gene system in HT-29 cells was used to measure levels of NF-kappaB activation after challenge with bifidobacteria or after bacterial pre-treatment following LPS challenge. IL-8 protein and pro-inflammatory gene expression was investigated using normal HT-29 cells. RESULTS: None of the bifidobacteria tested induced activation of nuclear factor kappaB (NF-kappaB) indicating that bifidobacteria themselves do not induce inflammatory events in IECs. However, six out of eight bifidobacteria tested inhibited lipopolysaccharide- (LPS-) induced NF-kappaB activation in a dose- and strain-dependent manner. In contrast, NF-kappaB activation in response to challenge with tumor necrosis factor-alpha (TNF-alpha) was affected by none of the tested bifidobacteria, indicating that the inhibitory effect of bifidobacteria is specific for LPS-induced inflammation in IECs. As shown with two of the six inhibition-positive bifidobacteria, LPS-induced inhibition of NF-kappaB activation was accompanied by a dose-dependent decrease of interleukin 8 (IL-8) secretion and by lower mRNA levels for IL-8, TNF-alpha, cyclooxygenase 2 (Cox-2), and intercellular adhesion molecule 1 (ICAM-1). CONCLUSION: Some strains of bifidobacteria are effective in inhibiting LPS-induced inflammation and thus might be appropriate candidates for probiotic intervention in chronic intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,187
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature reviews. Immunology · doi:10.1038/nri1132 · Cited by 1,796
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,485
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Harmsen, H. J. M., Wildeboer-Veloo, A. C. M., Raangs, G. C., Wagendorp, A. A., Klijn, N., BINDELS, J. G., & Welling, G. W. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200001000-00019 · Cited by 1,326
Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,245
Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,226
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A. S., Soper, P., McKaigney, C. J., Jijon, H. B., Yachimec, C., Doyle, J. S. G., Jewell, L. D., & Simone, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,096
Saavedra, J. M., Bauman, N. A., Perman, J. A., Yolken, R. H., Saavedra, J. M., Bauman, N. A., & Oung, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91708-6 · Cited by 958
Schell, M. A., Karmirantzou, M., Snel, ., Vilanova, D., Berger, B. W., Pessi, G., Zwahlen, M.-C., Desiere, F., Peer Bork, B., Delley, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212527599 · Cited by 942
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938
Pugin, J., Schürer-Maly, C., Leturcq, D., Moriarty, A., Ulevitch, R., & Tobias, P. (1993) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.90.7.2744 · Cited by 901
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., Simone, C. D., & Sartor, R. B. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41794.x · Cited by 743
Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
Resta-Lenert, S., & Barrett, K. E. (2003) · Gut · doi:10.1136/gut.52.7.988 · Cited by 642
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618
Franchimont, D. P., Vermeire, S., Housni, H. E., Pierik, M. J., Steen, K. V., Gustot, T., Quertinmont, E., Abramowicz, M., Gossum, A. V., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 596
TLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 577
McCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E. E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G. C., Kiely, B., Collins, J. K., et al. (2003) · Gut · doi:10.1136/gut.52.7.975 · Cited by 462
Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Härtung, T., Pascal Hols, A., & Mercenier, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504084102 · Cited by 443
Neurath, M. F., Fuss, I. J., Kelsall, B. L., Presky, D. H., Waegell, W., & Strober, W. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2605 · Cited by 432
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms
Otte, J., & Podolsky, D. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00341.2003 · Cited by 403
Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces
Harmsen, H. J. M., Raangs, G. C., He, T., Degener, J. E., & Welling, G. W. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.6.2982-2990.2002 · Cited by 401
Bernet‐Camard, M., Brassart, D., Neeser, J., & Servin, A. L. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.12.4121-4128.1993 · Cited by 381
Wright, S. D., Tobias, P. S., Ulevitch, R. J., & Ramos, R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.4.1231 · Cited by 354
Role of NF-κB in immune and inflammatory responses in the gut
Neurath, M. F., Becker, C., & Barbulescu, K. (1998) · Gut · doi:10.1136/gut.43.6.856 · Cited by 349
Strategic Compartmentalization of Toll-Like Receptor 4 in the Mouse Gut
Ortega-Cava, C. F., Ishihara, S., Rumi, M. A. K., Kawashima, K., Ishimura, N., Kazumori, H., Udagawa, J., Kadowaki, Y., & Kinoshita, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3977 · Cited by 346
Duchmann, R., Schmitt, E., Knolle, P. A., Büschenfelde, K. M. Z., & Neurath, M. F. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260432 · Cited by 338
Dianda, L., Hanby, A., Wright, N. A., Sebesteny, A., Hayday, A., & Owen, M. J. (1997) · Europe PMC (PubMed Central) · Cited by 337
Petrof, E. O., Kojima, K., Ropeleski, M. J., Musch, M. W., Tao, Y., Simone, C. D., & Chang, E. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.001 · Cited by 330
DNA from probiotic bacteria modulates murine and human epithelial and immune function
Jijon, H. B., Backer, J., Díaz, H., Yeung, H. P., Thiel, D., McKaigney, C. J., Simone, C. D., & Madsen, K. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.003 · Cited by 318
Furrie, E., Macfarlane, S., Thomson, G., Macfarlane, G. T., & Microbiology & Gut Biology Group, T. T. &. T. B. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02200.x · Cited by 282
Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A., & Takeda, Y. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2240-2247.2004 · Cited by 277
Labéta, M. O., Vidal, K., Nores, J. E. R., Arias, M. A., Vita, N., Morgan, B. P., Guillemot, J. C., Loyaux, D., Ferrara, P., Schmid, D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1807 · Cited by 254
The Role of Probiotic Cultures in the Prevention of Colon Cancer
Brady, L. J., Gallaher, D. D., & Busta, F. F. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.410s · Cited by 197
Contractor, N. V., Bassiri, H., Reya, T., Park, A. Y., Baumgart, D. C., Wasik, M. A., Emerson, S. G., & Carding, S. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.385 · Cited by 180
Gazouli, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i5.681 · Cited by 174
Yıldırım, Z., Winters, D. K., & Johnson, M. G. (1999) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1999.00629.x · Cited by 160
Possible Mechanisms by Which Pro- and Prebiotics Influence Colon Carcinogenesis and Tumor Growth
Reddy, B. S. (1999) · Journal of Nutrition · doi:10.1093/jn/129.7.1478s · Cited by 151
Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M., & Tanaka, R. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01461.x · Cited by 147
Pro- and prebiotics - the tasty guardian angels?
Simmering, R., & Blaut, M. (2001) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000512 · Cited by 128
Vidal, K., Donnet‐Hughes, A., & Granato, D. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.2057-2064.2002 · Cited by 125
A Cell-Based Assay System for Monitoring NF-κB Activity in Human HaCaT Transfectant Cells
Moon, K., Hahn, B.-S., Lee, J., & Kim, Y. S. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5059 · Cited by 103
A Polymorphism in the CD14 Gene is Associated with Crohn Disease
Klein, W., Tromm, A., Griga, T., Fricke, H., Folwaczny, C., Hocke, M., Eitner, K., Marx, M., Duerig, N., & Epplen, J. T. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202753416867 · Cited by 95
Soluble CD14 in human breast milk and its role in innate immune responses
Vidal, K., Labéta, M. O., Schiffrin, E. J., & Donnet‐Hughes, A. (2001) · Acta Odontologica Scandinavica · doi:10.1080/000163501750541219 · Cited by 84
Obana, N., Takahashi, S., Kinouchi, Y., Negoro, K., Takagi, S., Hiwatashi, N., & Shimosegawa, T. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520212504 · Cited by 75
Meijssen, M. A. C., Brandwein, S. L., Reinecker, H., Bhan, A. K., & Podolsky, D. K. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.3.g472 · Cited by 65
Research works printed but not linked: 1
- Staudt C. Wechselwirkungen von bifidobakterien mit darmepithelzellen und mit extrazellulären matrix- und plasmaproteinen[Thesis] German: University of Ulm; 2002;.
Cited by
Sorted by citations
Yeoh, Y. K., Zuo, T., Lui, G. C.-Y., Zhang, F., Liu, Q., Li, A. Y. L., Chung, A. C., Cheung, C. P., Tso, E. Y. K., Fung, K. S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323020 · Cited by 1,346
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568
Chemotherapy‐driven dysbiosis in the intestinal microbiome
Montassier, E., Gastinne, T., Vangay, P., Al‐Ghalith, G. A., Varannes, S. B. D., Massart, S., Moreau, P., Potel, G., Cochetiere, M. F. D. L., Batard, É., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13302 · Cited by 533
Metadata
- Authors
- Riedel, C. U.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Riedel, Christian U
- ORCID
- Riedel, Christian U
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2006
- Volume
- 12
- Issue
- 23
- Pages
- 3729
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4087466
- OpenAlex
- W1166213883
- Cited by
- 210
- References
- 57
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 15 · 2023: 8 · 2022: 16 · 2021: 18 · 2020: 16 · 2019: 8 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 3 · 2012: 13
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Bifidobacterium, probiotics, NF-κB activation, lipopolysaccharide, intestinal epithelial cells, HT-29 cells, anti-inflammatory activity, interleukin-8, TNF-α, cyclooxygenase-2, ICAM-1, chronic intestinal inflammation, strain-dependent effects
- MeSH terms
- Bifidobacterium, Dose-Response Relationship, Drug, Humans, Inflammation, Intestinal Mucosa, Lipopolysaccharides, RNA, Messenger, Tumor Necrosis Factor-alpha, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Neoplastic, Interleukin-8, NF-kappa B, Genes, Reporter, Intercellular Adhesion Molecule-1, HT29 Cells, Probiotics, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review